Barclays Maintains Equal-Weight on Johnson & Johnson, Raises Price Target to $175
Portfolio Pulse from jenniferd'souza@benzinga.com
Barclays analyst Matt Miksic maintains an Equal-Weight rating on Johnson & Johnson (NYSE:JNJ) and raises the price target from $171 to $175.
July 25, 2023 | 10:04 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays maintains an Equal-Weight rating on Johnson & Johnson and raises the price target from $171 to $175.
The news is directly related to Johnson & Johnson and is likely to have a positive impact on its stock price in the short term. The raised price target indicates that the analyst sees potential for the stock's price to increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100